GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Qiagen N.V.
Qiagen is a global provider of molecular testing technologies (Sample to Insight). Its stock price reflects the demand for diagnostics from laboratories, pharmaceutical companies, and scientists, which has surged during the pandemic and continues to grow.
Share prices of companies in the market segment - Dna
Qiagen is a global provider of molecular testing technologies. We consider it a DNA testing company. The chart below shows the overall dynamics of this sector, driven by demand for diagnostics from laboratories and pharmaceutical companies.
Broad Market Index - GURU.Markets
Qiagen is a leading global provider of molecular diagnostics and research technologies, from sample preparation to data analysis. As a key life sciences company, it is included in the GURU.Markets index. The chart below compares its performance to the overall market trend.
Change in the price of a company, segment, and market as a whole per day
QGEN - Daily change in the company's share price Qiagen N.V.
For Qiagen, a leader in molecular diagnostics, daily price changes are a measure of response to demand for lab tests. The graph of these fluctuations is unspectacular, but they are an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Dna
Qiagen N.V. is a leading provider of molecular diagnostics technologies. This chart shows the average daily volatility of the life sciences sector. Comparing it to QGEN, whose products are used in laboratories worldwide, helps assess its stability compared to biotech startups.
Daily change in the price of a broad market stock, index - GURU.Markets
Qiagen is a leading global provider of molecular diagnostics and research technologies. Its products are used in laboratories worldwide. The chart below illustrates overall market volatility, which can be used to assess how the healthcare sector, represented by Qiagen, is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Qiagen N.V.
Qiagen is a global leader in molecular diagnostics and laboratory technologies. Its year-over-year growth reflects the steady demand for its reagents and equipment from scientific and medical laboratories. The chart below tells the story of its indispensable role in the world of life sciences.
Annual dynamics of market capitalization of the market segment - Dna
Qiagen N.V. is a leading global provider of molecular diagnostics and research technologies. Its products are used to isolate and analyze DNA, RNA, and proteins. The graph shows how its key role in life sciences and healthcare ensures stable growth that outpaces the industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Qiagen is a Dutch company providing technologies for molecular diagnostics and scientific research. Its business is resilient to economic cycles thanks to consistent demand from the healthcare and scientific sectors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Qiagen N.V.
Qiagen, a provider of molecular research technologies, is a key player in life sciences. The monthly fluctuations on the chart reflect the demand for its reagents and equipment from diagnostic laboratories and research institutes worldwide.
Monthly dynamics of market capitalization of the market segment - Dna
This chart reflects the dynamics of the molecular diagnostics sector. For Qiagen, a leader, this is the backdrop. Its movements demonstrate stable demand for its reagents and equipment from research laboratories and clinics around the world.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Qiagen is a leading global provider of molecular diagnostics and research technologies. Its products are used in laboratories worldwide. Despite market fluctuations, as shown in the chart, Qiagen's business is more stable, as healthcare and research spending are less susceptible to economic downturns. The company is a vital part of the life sciences infrastructure.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Qiagen N.V.
Qiagen is a provider of molecular research technologies. The company's weekly stock price reflects news about demand for diagnostic tests (for example, for COVID-19 and other diseases) and funding levels in the life sciences sector.
Weekly dynamics of market capitalization of the market segment - Dna
Qiagen is a provider of molecular diagnostics technologies. Comparing its weekly performance with the life sciences sector reveals its market position. The chart allows one to assess how demand for its reagents and laboratory equipment allows it to keep pace with the industry or stay ahead of it through innovation.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Qiagen, as a supplier to the life sciences sector, may be less sensitive to economic cycles. Comparing its weekly performance with the broader market will help test this. The chart shows whether stable demand from laboratories truly makes its shares more defensive than the S&P 500.
Market capitalization of the company, segment and market as a whole
QGEN - Market capitalization of the company Qiagen N.V.
Qiagen's market capitalization tells the story of the key role of molecular diagnostics in modern medicine. The company's chart, which supplies DNA/RNA extraction and analysis technologies, reflects demand from laboratories worldwide. Its peak during the pandemic (for COVID tests) and subsequent dynamics illustrate how the market views the future of "testing everything."
QGEN - Share of the company's market capitalization Qiagen N.V. within the market segment - Dna
Qiagen is a leading global provider of molecular testing technologies used in science and clinical diagnostics. The company's market share reflects its critical role in the preparation and analysis of DNA and RNA samples. The chart below illustrates the importance of this key player in the era of personalized medicine and genetic research.
Market capitalization of the market segment - Dna
Qiagen is a global provider of molecular diagnostics and research technologies, from sample preparation to data analysis. The chart below shows the overall market capitalization of the DNA technologies sector. Its growth reflects the revolution in genetics and personalized medicine, where Qiagen instruments are the standard for many laboratories.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the cost of molecular diagnostics. Qiagen supplies technologies and reagents for DNA and RNA analysis used in medicine and science. Its market cap reflects the growing role of genetic information in our lives, from COVID-19 tests to personalized medicine.
Book value capitalization of the company, segment and market as a whole
QGEN - Book value capitalization of the company Qiagen N.V.
Qiagen's foundation is its manufacturing capabilities for molecular diagnostic reagents and equipment, as well as its extensive patent portfolio. This is the research-intensive capital that drives progress in genetics. The chart shows how the company has grown this technological and manufacturing base to serve laboratories and clinics worldwide.
QGEN - Share of the company's book capitalization Qiagen N.V. within the market segment - Dna
QIAGEN is a key supplier of molecular research tools. The company's strength lies in its factories producing reagents, test kits, and laboratory equipment. The chart shows the share of the global physical infrastructure for the production of "consumables" for science and medicine that the company controls.
Market segment balance sheet capitalization - Dna
Qiagen, a leader in molecular diagnostics, is a capital-intensive business. It requires ownership of factories to produce reagents and equipment. The BCap_Seg chart for the life sciences sector shows that ensuring quality and scale requires a significant resource base.
Book value of all companies included in the broad market index - GURU.Markets
Qiagen's assets comprise a global network of manufacturing sites and laboratories where reagents and equipment for molecular diagnostics are created. Its book value reflects the complex scientific and manufacturing infrastructure that underpins DNA "reading." The chart below shows the physical weight of this biotech supplier.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Qiagen N.V.
Qiagen's balance sheet consists of its factories and laboratories. The high premium the market pays reflects its key role in biomedical research. Its reagents and equipment are "scientific consumables." The chart shows how much investors value this stable and indispensable business model.
Market to book capitalization ratio in a market segment - Dna
Qiagen is a global leader in molecular diagnostics. The company supplies equipment and reagents for DNA and RNA analysis. The chart demonstrates the high valuation of its technologies and strong position in the life sciences market, which significantly exceeds the value of its physical activities.
Market to book capitalization ratio for the market as a whole
Qiagen is a leading provider of molecular diagnostics and research technologies. The company's value is determined by its broad portfolio of proprietary products and reagents, not just its manufacturing facilities. This chart shows the market premium paid for its research-intensive products and leading position in its niche.
Debts of the company, segment and market as a whole
QGEN - Company debts Qiagen N.V.
Qiagen, a provider of molecular diagnostics and research technologies, uses debt to finance acquisitions and investments in new product development. In the fast-growing life sciences sector, debt accelerates innovation. This chart shows how the company uses leverage to strengthen its leadership in the life sciences market.
Market segment debts - Dna
Qiagen is a leading provider of molecular diagnostics and research technologies. The company operates in the fast-growing life sciences sector. Debt can be used to fund R&D or to acquire companies with promising technologies. This chart helps us understand whether Qiagen prefers organic or M&A growth strategies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Qiagen N.V.
Qiagen is a leading provider of molecular diagnostics technologies. The company continually invests in the development of new tests and equipment. This chart shows how it funds its innovations. It helps assess the extent to which its growth is organic and whether its debt burden poses risks to its long-term technological leadership.
Market segment debt to market segment book capitalization - Dna
Qiagen is a leading global provider of molecular diagnostics and research technologies. Innovations in genetics require continuous investment in R&D. The chart shows how the company's leverage strategy for maintaining technological leadership compares to the overall financial strength of the life sciences sector.
Debt to book value of all companies in the market
Qiagen, a provider of molecular diagnostics technologies, invests in R&D to maintain its leadership. This chart shows how significant its debt strategy for funding innovation is relative to the overall market capitalization of all sectors.
P/E of the company, segment and market as a whole
P/E - Qiagen N.V.
Qiagen is a leading global provider of molecular diagnostics and research technologies. This chart shows how the market perceives its scientific potential. This indicator's dynamics reflect demand for its reagents and equipment from laboratories and pharmaceutical companies, as well as the success of new diagnostic tests, such as those for infectious diseases.
P/E of the market segment - Dna
Qiagen is a leading provider of molecular diagnostics and scientific research technologies. This chart shows the average rating for the Life Science Tools sector. Comparisons with this rating help understand the premium the market places on Qiagen for its broad product portfolio and deep integration into laboratory workflows.
P/E of the market as a whole
Qiagen is a leading global provider of molecular diagnostics and research technologies. The company provides tools for working with DNA and RNA. This chart reflects the overall sentiment in the healthcare sector. Qiagen's valuation depends on more specific factors: the pace of scientific research, the emergence of new epidemics, and the introduction of personalized medicine into clinical practice.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Qiagen N.V.
Qiagen is a leading provider of molecular diagnostics and research technologies. This chart illustrates market expectations for demand for its reagents and equipment from laboratories and pharmaceutical companies. The trend reflects growth forecasts in the life sciences and molecular diagnostics segments.
%20P%2FE%20Qiagen%20N.V.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Qiagen-N.V.&v=1772513844487 "Chart of the company's future (projected) P/E Qiagen N.V.")
Future (projected) P/E of the market segment - Dna
Qiagen is a leading global provider of molecular diagnostics and research technologies (from sample preparation to analysis). This chart shows average profitability expectations in the sector. It helps understand how the market perceives demand for Qiagen's products in a post-pandemic world and its role in the development of personalized medicine.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772513844506 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
Qiagen N.V. is a global provider of molecular diagnostics and research technologies, offering solutions for sample processing and analysis. This chart shows overall investor sentiment. For a company whose products are used in laboratories worldwide, it reflects the market's willingness to invest in the healthcare and research sectors.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513844528 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Qiagen N.V.
Qiagen is a leading global provider of molecular testing technologies used in science and clinical diagnostics. The financial performance shown in this chart depends on laboratory demand for its reagents and equipment. This trend reflects growth in genetic research and personalized medicine.
Profit of companies in the market segment - Dna
Qiagen is a leading global provider of molecular diagnostics and research technologies. The company offers solutions for the extraction and analysis of DNA, RNA, and proteins from biological samples. The data in the graph illustrates how innovations in genetic research are driving profitability in the biotechnology sector, where Qiagen is a key supplier.
Overall market profit
Qiagen is a global provider of molecular diagnostics and scientific research technologies. Its products are used in laboratories worldwide for DNA and RNA analysis. Demand for these instruments reflects the level of funding for science and healthcare. The overall economic situation, shown in this chart, influences public and private research budgets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Qiagen N.V.
Qiagen is a leading global provider of molecular testing technologies (Sample to Insight). The company's products are used in scientific research, pharmaceuticals, and diagnostics. The revenue forecast in this chart reflects analysts' expectations for demand for diagnostic tests and research tools, particularly in the life sciences.
%20profit%20of%20the%20company%20Qiagen%20N.V.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Qiagen-N.V.&v=1772513844755 "Graph of future (projected) profit of the company Qiagen N.V.")
Future (predicted) profit of companies in the market segment - Dna
Qiagen is a leading global provider of molecular testing technologies (Sample to Insight), used in science, applied testing, and molecular diagnostics. This chart shows the revenue forecast for the DNA Technologies sector, allowing you to assess how Qiagen's innovations in diagnostics and research position it within the industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772513844777 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
Qiagen is a leading provider of molecular diagnostics and scientific research technologies. Demand for the company's products depends on funding in the life sciences sector. This dynamic, reflecting the overall economic situation, impacts the budgets of research institutes and hospitals, which are Qiagen's primary customers.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513844781 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Qiagen N.V.
Qiagen is a leading global provider of molecular diagnostics and research technologies. This chart shows how the market values the company's revenue, whose products are used in laboratories worldwide. This sales estimate reflects the stable demand for its reagents and equipment in science and medicine.
P/S market segment - Dna
Qiagen N.V. is a leading global provider of molecular diagnostics and life sciences technologies. The company offers solutions for the extraction and analysis of DNA, RNA, and proteins from biological samples. This chart shows how the market values companies in the sector, providing insight into the value of Qiagen's technologies and products.
P/S of the market as a whole
Qiagen is a leading global provider of molecular testing technologies ("Sample to Insight"). Its products are used in scientific research, pharmaceuticals, and diagnostics. This chart helps understand how the market values companies that are key suppliers of tools for the biotech and medical industries, laying the foundation for scientific discovery.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Qiagen N.V.
Qiagen is a leading provider of molecular diagnostics and research technologies, from sample preparation to results analysis. This chart shows how the market values the company relative to its future sales. It reflects investor expectations for growing demand for genetic testing and personalized medicine.
%20P%2FS%20Qiagen%20N.V.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Qiagen-N.V.&v=1772513844882 "The graph of the company's future (projected) P/S Qiagen N.V.")
Future (projected) P/S of the market segment - Dna
Qiagen is a leading global provider of molecular diagnostics and scientific research technologies. The company provides tools for the extraction and analysis of DNA, RNA, and proteins. Its products are used in laboratories worldwide. This metric reflects how the market perceives its future sales relative to other companies in the life sciences sector.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772513844899 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
Qiagen is a global provider of molecular diagnostics and research technologies. Demand for its products comes from laboratories that analyze biological samples. This general expectations chart for QGEN is not a direct driver. The company's growth depends on trends in healthcare, scientific research, and R&D funding, rather than the general economic cycle.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513844910 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Qiagen N.V.
This graph illustrates the key role of diagnostics in modern medicine and science. For Qiagen, a global provider of molecular research technologies, it reflects sales of consumables and equipment. Laboratories worldwide use their products to isolate and analyze DNA, RNA, and proteins.
Sales of companies in the market segment - Dna
Qiagen N.V. is a leading provider of molecular diagnostics and research technologies, from sample preparation to analysis. Demand for its products is driven by funding in life sciences and clinical diagnostics. This chart shows how growth in personalized medicine and genetic testing is driving Qiagen's revenue.
Overall market sales
Qiagen is a leading global provider of molecular diagnostics and scientific research technologies. Its products are used in laboratories worldwide for DNA and RNA analysis. Demand for Qiagen's solutions reflects the growing market for personalized medicine and biotechnology, which are among the fastest-growing and most innovative sectors of the modern economy.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Qiagen N.V.
Qiagen is a leading global provider of molecular diagnostics and biomedical research technologies. The company's sales are driven by demand for disease detection tests and scientific laboratory tools. This chart shows analyst forecasts for the development of the genetic research and personalized medicine market.
%20sales%20of%20the%20company%20Qiagen%20N.V.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Qiagen-N.V.&v=1772513845051 "Schedule of future (projected) sales of the company Qiagen N.V.")
Future (projected) sales of companies in the market segment - Dna
Qiagen N.V. is a leading provider of molecular diagnostics and life sciences technologies. The DNA analysis sector forecast reflects the pace of scientific progress and helps understand how the growth of personalized medicine and genetic research is driving sustainable demand for Qiagen's products and solutions.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772513845105 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
QIAGEN is a leading provider of molecular diagnostics and research technologies. Demand for its products depends on funding in the life sciences and diagnostic laboratory budgets. The overall economic environment, as reflected here, influences public and private investment in healthcare and biotechnology, which is a key driver of QIAGEN's growth.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513845133 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Qiagen N.V.
Qiagen, a global provider of molecular diagnostics and research technologies, demonstrates its ability to profit from consumables in this chart. The company's profitability is based on consistent sales of reagents and assay kits used with its installed base of instruments in laboratories worldwide.
Market segment marginality - Dna
Qiagen is a leading global provider of molecular testing technologies (Sample to Insight). This chart reflects average profitability in the life sciences industry. Its broad portfolio of products used in science and diagnostics and strong market position enable the company to maintain profitability that often exceeds the industry average.
Market marginality as a whole
Qiagen N.V. is a leading global provider of molecular diagnostics and research technologies (sample preparation and testing). This chart shows the company's overall profit margin. It illustrates Qiagen's business as a "shovel supplier" during the biotech gold rush. Its consumables and equipment are essential for research and diagnostics.
Employees in the company, segment and market as a whole
Number of employees in the company Qiagen N.V.
Qiagen is a leading global provider of molecular diagnostics and life sciences technologies. Its team of scientists and engineers creates innovative products. Growth, as seen in this graph, is often driven by the launch of new testing platforms or increased demand for reagents, as was the case during the pandemic.
Share of the company's employees Qiagen N.V. within the market segment - Dna
QIAGEN is a leading global provider of molecular diagnostics and research technologies, whose DNA and RNA extraction kits are the industry standard. This chart demonstrates its scientific dominance. It reflects the significant share of biologists, geneticists, and molecular diagnostics specialists QIAGEN represents in this industry.
Number of employees in the market segment - Dna
Qiagen is a leading global provider of molecular diagnostics and scientific research technologies. This chart shows its growth in the life sciences. The company employs scientists and engineers to create tools that enable other researchers to make breakthroughs in genetics, medicine, and forensics.
Number of employees in the market as a whole
Qiagen is a leading provider of molecular diagnostics and research technologies. Demand for its products comes from laboratories, hospitals, and pharmaceutical companies. Overall economic growth, reflected in employment growth, supports stable funding for healthcare and research, which are Qiagen's primary markets.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Qiagen N.V. (QGEN)
Qiagen is a global leader in molecular diagnostics and research technologies. This chart demonstrates the science-intensive nature of its business. Its high capitalization per employee reflects the team's dedication to creating unique reagents and tools that serve as consumables for genetic research worldwide.
%20of%20the%20company%20Qiagen%20N.V.%20(QGEN)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Qiagen-N.V.-QGEN&v=1772513845457 "Chart of market capitalization per employee (in thousands of dollars) of the company Qiagen N.V. (QGEN)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
Qiagen N.V. is a leading provider of Sample-to-Insight technologies for molecular diagnostics and research. They produce reagents and instruments for DNA/RNA analysis. This chart reflects the industry average market capitalization per employee. It helps assess how the market values Qiagen's technology platform and its consumables per employee.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772513845475 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
Qiagen is a leading global provider of molecular diagnostics and research technologies (from sample preparation to analysis). The company's business is based on the sale of reagents and equipment. This chart reflects the company's high employee value, as its intellectual property and global reach allow it to be a key player in the life sciences industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513845479 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Qiagen N.V. (QGEN)
Qiagen is a leading provider of molecular research and diagnostic technologies ("sample to insight"). They produce reagents and instruments for DNA/RNA extraction and analysis. This chart shows how profitable their laboratory consumables business is. It measures how much revenue each scientist and manufacturing employee generates by supplying the scientific world with testing tools.
%20Chart%20Qiagen%20N.V.%20(QGEN)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Qiagen-N.V.-QGEN&v=1772513845494 "Company Profit Per Employee (in thousands of dollars) Chart Qiagen N.V. (QGEN)")
Profit per employee (in thousands of dollars) in the market segment - Dna
Qiagen is a leader in molecular diagnostics (R&D, testing). This chart shows the benchmark for DNA (Life Science Tools). The average profit per employee is high here. It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from blades (single-use reagents, software), generated by a small staff.
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772513845505 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
Qiagen is a leading provider of molecular diagnostics and research technologies. The company supplies reagents and equipment that are the building blocks of modern biology. This chart shows how selling consumables and automated systems to thousands of laboratories worldwide creates a scalable and profitable business.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513845509 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Qiagen N.V. (QGEN)
Qiagen is a leading provider of molecular diagnostics and research technologies. This chart demonstrates the value of its science-intensive products. Its high revenue per employee is a result of sales of consumables and laboratory equipment worldwide, reflecting the company's commercial performance in the global life sciences industry.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Qiagen-N.V.-QGEN&v=1772513845535 "Sales chart per company employee Qiagen N.V. (QGEN)")
Sales per employee in the market segment - Dna
Qiagen is a leading provider of molecular diagnostic technologies (DNA, RNA). They serve both scientific laboratories and clinics. This metric reflects how productive their R&D and manufacturing teams are in creating and selling reagents and equipment. A comparison with the sector demonstrates their competitiveness in the life sciences field.
Sales per employee for the market as a whole
Qiagen N.V. is a leading global provider of molecular diagnostics and research technologies ("Sample to Insight"). They produce reagents and equipment for DNA/RNA extraction and analysis. This graph shows how much revenue each employee generates. It reflects the value of their consumables (which are used constantly) and diagnostic tests, which are standard in many laboratories worldwide.
Short shares by company, segment and market as a whole
Shares shorted by company Qiagen N.V. (QGEN)
Qiagen N.V. is a leading provider of molecular diagnostics and research technologies. The company produces reagents and equipment for the extraction and analysis of DNA, RNA, and proteins. This chart shows bearish bets. Bears may expect a sharp decline in testing demand (related to COVID), which has inflated the company's revenue, or a reduction in biotech research funding.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Qiagen-N.V.-QGEN&v=1772513845642 "Short Shares Chart for the Company Qiagen N.V. (QGEN)")
Shares shorted by market segment - Dna
Qiagen N.V. is a leading provider of molecular diagnostics and research technologies (including DNA/RNA extraction). This chart shows overall short positions in the Life Sciences Tools sector. If it is high, investors expect budget cuts for biotech and academic research, which will reduce demand for Qiagen's consumables and equipment.
Shares shorted by the overall market
Qiagen (QGEN) is a key supplier of consumables and instruments for molecular diagnostics and scientific laboratories. They are the "gold standard" in sample preparation. This chart measures the overall level of fear. When pessimism rises, investors fear that R&D budgets in biotech and pharma (QGEN's clients) will be frozen in anticipation of a recession.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Qiagen N.V. (QGEN)
Qiagen is a science supplier. They sell laboratory consumables and DNA testing equipment. **This chart** measures momentum. A strong report showing rising R&D budgets at their biotech clients or the launch of a new diagnostic platform could trigger a rally that would push **This chart** into overbought territory (above 70).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Qiagen-N.V.-QGEN&v=1772513845731 "RSI 14 indicator chart for the company's stock Qiagen N.V. (QGEN)")
RSI 14 Market Segment - Dna
Qiagen (QGEN) is "from test tube to results." They are a global leader in molecular diagnostics technologies, providing laboratories with tools for DNA/RNA extraction and analysis. This metric measures the "temperature" of the sector. It helps us understand: is QGEN oversold due to a post-COVID hangover or is there a general cooling off in the sector?
RSI 14 for the overall market
Qiagen (QGEN) is a leading provider of molecular testing technologies (from sample preparation to diagnostics). Their products are used in science and medicine. This market climate chart is important. After the pandemic boom, demand for testing has returned to normal. In times of panic, investors may fear that labs and pharmaceutical companies will cut research spending, which will hurt QGEN.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast QGEN (Qiagen N.V.)
Qiagen is a leading global provider of molecular diagnostics (DNA/RNA) technologies. Their reagents and equipment are used in laboratories for disease detection and scientific research. This chart is a collective 12-month forecast from analysts. It reflects their expectations for demand for laboratory tests (non-COVID) and the growth of their digital platform, QIAstat-Dx.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-QGEN-Qiagen-N.V.&v=1772513845837 "A chart showing analyst consensus forecasts for the expected stock price. QGEN (Qiagen N.V.)")
The difference between the consensus estimate and the actual stock price QGEN (Qiagen N.V.)
Qiagen is a Dutch company and a global leader in sample preparation technologies. They create kits and systems that enable labs to isolate and analyze DNA, RNA, and proteins from any sample. This chart shows how analysts estimate demand for their consumables in the post-pandemic world. It reflects the gap between the target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-QGEN-Qiagen-N.V.&v=1772513845852 "A chart showing the difference between the consensus forecast and the actual stock price. QGEN (Qiagen N.V.)")
Analyst consensus forecast for stock prices by market segment - Dna
Qiagen is a global supplier of consumables and tests for molecular laboratories. The company helps scientists and doctors extract DNA/RNA from samples and analyze them. This chart shows general expectations for the DNA technology sector. It reflects whether experts believe the molecular diagnostics market will grow.
Analysts' consensus forecast for the overall market share price
Qiagen N.V. is a global leader in molecular diagnostics, particularly in sample preparation for DNA/RNA analysis. Market expectations, as shown in this chart, impact R&D budgets. If experts anticipate a downturn, biotech companies and research centers (their clients) cut research spending, which hurts Qiagen.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Qiagen N.V.
Qiagen is a key supplier to molecular diagnostics and scientific research. Their strength lies in their sample preparation consumables (DNA/RNA), which are the first and critical step in any genetic test. This chart reflects their razor-and-blades model. It measures the recurring demand for their reagents from laboratories worldwide.
AKIMA Market Segment Index - Dna
Qiagen is a global leader in molecular diagnostics; the company supplies equipment and (more importantly) consumables for sample preparation and testing (DNA, RNA) in laboratories. This aggregate metric evaluates companies. The graph shows the sector average. This benchmark: to what extent does Qiagen's indispensable role in R&D (and its razor-sharp model) distinguish it from the average competitor?
The AKIM Index for the overall market
Qiagen is a global leader in molecular diagnostics. The company produces reagents and sample preparation equipment (DNA, RNA) for analysis. These are the picks and shovels of the biotech industry. This chart, reflecting the market average, is the backdrop. It helps assess how Qiagen, whose business depends on R&D budgets, fits into the overall macroeconomic picture.
